Eli Lilly has built the case for its oral GLP-1 agonist orforglipron with two more phase 3 readouts, including new data showing that it can improve blood glucose compared to a go-to therapy for type 2 ...
Podcasts Music Commentary Song of the Day From MPR News Music lovers from 89.3 The Current comb through mountains of music to choose the best new, independent, and unreleased songs to share with you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback